2,4-Dichlorothieno[3,2-d]pyrimidine → HCID 71548635, compound
Reaction equation
Cl[C:2]1[N:3]=[C:4](Cl)[C:5]2[S:10][CH:9]=[CH:8][C:6]=2[N:7]=1.[S:12]1(=[O:24])(=[O:23])[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=2[CH2:16][NH:15][CH2:14][CH2:13]1>>[O:23]=[S:12]1(=[O:24])[C:18]2[CH:19]=[CH:20][CH:21]=[CH:22][C:17]=2[CH2:16][N:15]([C:2]2[N:3]=[C:4]([NH:3][CH2:4][CH2:5][CH2:6][NH2:7])[C:5]3[S:10][CH:9]=[CH:8][C:6]=3[N:7]=2)[CH2:14][CH2:13]1Participants
3
Procedure
The title compound was prepared in analogy to Example 1-1 in Scheme 1 by using 2,4-dichlorothieno[3,2-d]pyrimidine and propane-1,3-diamne, followed by reaction with 2,3,4,5-tetrahydro-1,4-benzothiazepine-1,1-dioxide. MS obsd. (ESI+) [(M+H)+] 404, 1H NMR (400 MHz, METHANOL-d4) δ ppm 8.04 (d, J=7.3 Hz, 1H), 7.73 (d, J=7.1 Hz, 1H), 7.46-7.57 (m, 2H), 7.34-7.42 (m, 1H), 7.10 (d, J=5.3 Hz, 1H), 5.19 (br. s., 2H), 3.76 (br. s., 2H), 3.44-3.54 (m, 4H), 3.00 (t, J=6.1 Hz, 2H), 1.88 (m, 2H).
Sources & evidence
- ORD record
- ord-f05ffe1ef82e474d97a29431aca13f37
- Source dataset
- uspto-grants-2013_12
- Patent number
- US08604019B2
Reaction notes
Loading…